PAR
Click for more information
1.96% 25.0¢ paradigm biopharmaceuticals limited..

Video: Paradigm Biopharmaceuticals (ASX:PAR) conducting Phase 3 osteoarthritis trial, page-25

  1. oxxa23
    5,957 Posts.
    lightbulb Created with Sketch. 1138
    clock Created with Sketch.
    22/02/24
    22:39
    Post #: 72547855
    Sure, but, he likely has the numbers to call an egm and make serious dents should he feel the need to...
    PAR Price at posting: 37.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 7  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

POL Polymetals finalises acquisition of Endeavor silver-lead-zinc mine in NSW's Cobar Basin
right-arrow Created with Sketch.
GML Gateway Mining sells WA Eastern Montague gold project to Brightstar for $14M – half of that in shares
right-arrow Created with Sketch.
CPV ClearVue shares up 15% as it inks deal to enter Middle East and Indian construction markets
right-arrow Created with Sketch.
TG1 TechGen Metals kicks off airborne geophys survey at Sally Downs copper play – a first for the permit
right-arrow Created with Sketch.
KAI Pilbara Minerals buys land off Kairos part of its York gold project for $20M – and a 2% royalty on any PLS gold sales
right-arrow Created with Sketch.
AVH Avita boosts skin restoration product portfolio with 'dermal matrix' – a kind of next-level gauze made of fake skin
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
25.0¢ 		Change
-0.005(1.96%) 		Mkt cap ! $87.44M
Open High Low Value Volume
25.0¢ 25.5¢ 25.0¢ $13.08K 51.83K

Buyers (Bids)

No. Vol. Price($)
5 133489 25.0¢
 

Sellers (Offers)

Price($) Vol. No.
26.0¢ 25012 2
View Market Depth
Last trade - 16.10pm 02/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.